^
BIOMARKER:

ER Y537S + ER positive

i
Other names: ESR1, Era, ESR, NR3A1, ER, ER beta
Entrez ID:
News
Twitter
Trials
ER Y537S + ER positive
HER2 Negative Breast Cancer
palbociclib
Sensitive: C3 – Early Trials
ESMO 2021 - 4 weeks
ER Y537S + ER positive
HER2 Negative Breast Cancer
H3B-6545
Sensitive: C3 – Early Trials